Olympus Co. (OTCMKTS:OCPNY – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $18.00 and traded as low as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares changing hands.
Olympus Trading Down 1.4%
The business’s 50-day simple moving average is $18.00 and its two-hundred day simple moving average is $18.00. The company has a current ratio of 1.99, a quick ratio of 1.48 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $23.15 billion, a PE ratio of 21.95, a PEG ratio of 1.07 and a beta of 0.70.
Olympus Company Profile
Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.
In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.
See Also
- Five stocks we like better than Olympus
- The biggest story of 2026 (free access)
- Your name isn’t on our protected list yet
- Silver paying 20% dividend. Plus 68% share gains
- What happened in Cyprus could be coming here
- What Expenses Can Be Deducted From Capital Gains Tax This Year?
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
